Clinical Observation and Evaluation of CGF in the Treatment of Androgenic Alopecia

The study evaluated the efficacy of concentrated growth factor (CGF) injections in 60 patients with androgenic alopecia. Patients received 0.1 ml CGF injections into the alopecia area every 30-35 days for a total of 6 treatments. Results showed that 52 out of 58 patients who completed the treatment experienced significant improvement, with increased hair density, hair follicle density, and hair diameter. No adverse effects were reported, and patient satisfaction was 93%. The study concluded that CGF treatment is effective, safe, and beneficial for improving hair loss symptoms in androgenic alopecia patients.